Source comparison
IGF-1 LR3 Versus Native IGF-1, Regular IGF-1, and Mecasermin
Native IGF-1 is the endogenous insulin-like growth factor involved in growth and metabolism, while mecasermin is recombinant human IGF-1 approved for specific severe primary IGF-1 deficiency indications [3] [7] [20]. IGF-1 LR3 differs from native IGF-1 because
This comparison does not assign a generated winner or score.
- Native IGF-1 is the endogenous insulin-like growth factor involved in growth and metabolism, while mecasermin is recombinant human IGF-1 approved for specific severe primary IGF-1 deficiency indications [3] [7] [20]. IGF-1 LR3 differs from native IGF-1 because it is a modified analog with altered binding-protein interaction described in laboratory research [1].
- Unlike regular IGF-1 or approved mecasermin, IGF-1 LR3 lacks an approved therapeutic label, established dosing instructions, and a defined clinical safety profile [2] [3]. That difference should guide every discussion about benefits, risks, and evidence.